Medeon Biodesign, Inc. (6499.TWO)

TWD 38.3

(-4.73%)

Net Debt Summary of Medeon Biodesign, Inc.

  • Medeon Biodesign, Inc.'s latest annual net debt in 2023 was -1.19 Billion TWD , down -268.87% from previous year.
  • Medeon Biodesign, Inc.'s latest quarterly net debt in 2024 Q2 was -754.75 Million TWD , up 28.92% from previous quarter.
  • Medeon Biodesign, Inc. reported annual net debt of -284.98 Million TWD in 2022, up 59.58% from previous year.
  • Medeon Biodesign, Inc. reported annual net debt of -705.08 Million TWD in 2021, down -10.97% from previous year.
  • Medeon Biodesign, Inc. reported quarterly net debt of -1.06 Billion TWD for 2024 Q1, up 10.84% from previous quarter.
  • Medeon Biodesign, Inc. reported quarterly net debt of -469.48 Million TWD for 2023 Q1, down -64.74% from previous quarter.

Annual Net Debt Chart of Medeon Biodesign, Inc. (2023 - 2019)

Historical Annual Net Debt of Medeon Biodesign, Inc. (2023 - 2019)

Year Net Debt Net Debt Growth
2023 -1.19 Billion TWD -268.87%
2022 -284.98 Million TWD 59.58%
2021 -705.08 Million TWD -10.97%
2020 -635.36 Million TWD -79.62%
2019 -353.73 Million TWD 0.0%

Peer Net Debt Comparison of Medeon Biodesign, Inc.

Name Net Debt Net Debt Difference
St.Shine Optical Co.,Ltd. -1.4 Billion TWD 15.026%
Bioteque Corporation -459.67 Million TWD -159.057%
Chi Sheng Pharma & Biotech Co., Ltd -261.04 Million TWD -356.167%
Sunder Biomedical Tech. Co., Ltd. 394.6 Million TWD 401.778%
BenQ Medical Technology Corporation 405.72 Million TWD 393.506%
Pacific Hospital Supply Co., Ltd -307.54 Million TWD -287.197%
Unicon Optical Co., Ltd. 41.06 Million TWD 2999.627%
Formosa Optical Technology Co.,Ltd. 2.78 Billion TWD 142.779%
Concord Medical Co., Ltd. 104.78 Million TWD 1236.484%
Crystalvue Medical Corporation -248.31 Million TWD -379.552%
Perfect Medical Industry Co., Ltd. 50.55 Million TWD 2455.632%
ICARES Medicus, Inc. -259.62 Million TWD -358.662%
Lagis Enterprise Co., Ltd. 87.79 Million TWD 1456.348%
Amed Co., Ltd. 153.75 Million TWD 874.511%